Skip to content

Health Subcommittee

HOUSE · SUBCOMMITTEE118th Congress

Recent meetings and hearings

  1. Sep 10, 2024 · Hearing

    Evaluating FDA Human Foods and Tobacco Programs
  2. Jul 23, 2024 · Hearing

    Are CDC's Priorities Restoring Public Trust and Improving the Health of the American People
  3. Jun 13, 2024 · Hearing

    Checking-In on CMMI: Assessing the Transition to Value-Based Care
  4. May 22, 2024 · Hearing

    Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices
  5. May 16, 2024 · Markup

    23 Pieces of Legislation
  6. Apr 30, 2024 · Hearing

    Legislative Proposals to Increase Medicaid Access and Improve Program Integrity
  7. Apr 17, 2024 · Hearing

    Fiscal Year 2025 Department of Health and Human Services Budget
  8. Apr 16, 2024 · Hearing

    Examining Health Sector Cybersecurity in the Wake of the Change Healthcare Attack
  9. Apr 10, 2024 · Hearing

    Legislative Proposals to Support Patient Access to Telehealth Services
  10. Mar 21, 2024 · Hearing

    Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule
  11. Mar 12, 2024 · Markup

    19 Pieces of Legislation
  12. Feb 29, 2024 · Hearing

    Legislative Proposals to Support Patients with Rare Diseases
  13. Feb 14, 2024 · Hearing

    Legislative Proposals to Support Patients and Caregivers
  14. Jan 31, 2024 · Hearing

    Health Care Spending in the United States: Unsustainable for Patients, Employers, and Taxpayers
  15. Nov 29, 2023 · Meeting

    Understanding How AI is Changing Health Care
  16. Nov 15, 2023 · Meeting

    Markup of 21 Pieces of Legislation
  17. Oct 25, 2023 · Meeting

    Supporting Access to Long-Term Services and Supports: An Examination of the Impacts of Proposed Regulations on Workforce and Access to Care
  18. Oct 19, 2023 · Meeting

    What's the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors
  19. Sep 19, 2023 · Meeting

    Examining Policies to Improve Seniors' Access to Innovative Drugs, Medical Devices, and Technology
  20. Sep 14, 2023 · Meeting

    Legislative Proposals to Prevent and Respond to Generic Drug Shortages
  21. Jul 18, 2023 · Meeting

    Innovation Saves Lives: Evaluating Medicare Coverage Pathways for Innovative Drugs, Medical Devices, and Technology
  22. Jul 13, 2023 · Markup

    Markup of 17 Pieces of Legislation
  23. Jun 21, 2023 · Meeting

    Responding to America's Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT Act
  24. Jun 14, 2023 · Meeting

    Examining Proposals that Provide Access to Care for Patients and Support Research for Rare Diseases
  25. Jun 13, 2023 · Hearing

    Legislative Solutions to Bolster Preparedness and Response for All Hazards and Public Health Security Threats
  26. Jun 9, 2023 · Meeting

    Addressing the Opioid Crisis: Examining the SUPPORT Act Five Years Later
  27. May 17, 2023 · Meeting

    Subcommittee on Health Markup
  28. May 11, 2023 · Meeting

    Preparing for and Responding to Future Public Health Security Threats
  29. Apr 26, 2023 · Hearing

    Lowering Unaffordable Costs: Legislative Solutions to Increase Transparency and Competition in Health Care
  30. Apr 19, 2023 · Hearing

    Examining Existing Federal Programs to Build a Stronger Health Workforce and Improve Primary Care
  31. Mar 30, 2023 · Hearing

    Reauthorization of the Animal Drug User Fee Programs
  32. Mar 29, 2023 · Hearing

    Fiscal Year 2024 Department of Health and Human Services Budget
  33. Mar 28, 2023 · Hearing

    "Lowering Unaffordable Costs: Examining Transparency and Competition in Health Care"
  34. Mar 8, 2023 · Meeting

    Subcommittee on Health Markup of Five Pieces of Legislation
  35. Feb 1, 2023 · Hearing

    "Lives Worth Living: Addressing the Fentanyl Crisis, Protecting Critical Lifelines, and Combatting Discrimination Against Those with Disabilities"

About this data

Final state of this Congress (January 3, 2023 – January 3, 2025). These counts will not change.

Measures can appear in more than one stage. These counts describe recorded activity and outcomes, not a sequential conversion funnel.

Counts are computed from this corpus. They are not official committee statistics.

The hearings list counts committee meetings. A hearing stage is shown only when a hearing record names a measure.

  • Referred. Measures referred to this committee.
  • Hearing. Measures linked to a hearing that names the measure. Meetings, and hearings that do not name a measure, are not included.
  • Marked up. Measures this committee marked up.
  • Reported. Measures this committee reported.
  • Floor. Referred measures with a recorded roll-call vote, or a Congressional Record consideration link. Voice votes and unanimous consent are not roll calls, so they are not in this count. If this Congress has no Record links, the count is roll calls only.
  • Passed a chamber. Referred measures whose recorded status is passage of a chamber, agreement, or a later outcome. This includes passage without a roll-call vote.
  • Enacted. Referred measures that became law, or whose recorded outcome is enacted.

House roster files label the chair and vice chair. They do not label a ranking member. The minority member listed first is shown as ranking member.

Meeting times are published in UTC and shown here in Eastern Time.

Former members were on an earlier official roster snapshot and absent from a later one. Dates are snapshot bounds, not appointment dates.

Data quality